Literature DB >> 25154440

Ginsenoside Rh1 induces mouse osteoblast growth and differentiation through the bone morphogenetic protein 2/runt-related gene 2 signalling pathway.

Muhammad Hanif Siddiqi1, Muhammad Zubair Siddiqi, Sungeun Ahn, Yeon-Ju Kim, Deok Chun Yang.   

Abstract

OBJECTIVES: This study aimed to investigate the stimulative and pharmacological effects of ginsenoside Rh1 (hereinafter referred to as: Rh1) on differentiation and mineralization of osteoblast and its possible mechanism of action on the expression of bone morphogenetic protein 2 (BMP-2)/Runt-related gene 2 (Runx2) signalling pathways using mouse preosteoblastic MC3T3-E1 cell line as in-vitro model.
METHODS: An in-vitro stimulative activity of Rh1 was assessed by analyzing alkaline phosphatase activity (ALP), type-I collagen (Coll-I) synthesis, mineralization and glutathione content. Its antioxidant activity was measured by evaluating the reactive oxygen species (ROS) production in the presence of antimycin A (AMA), one of the mitochondrial dysfunction factors. The level of BMP-2/Runx2 signal-regulated osteoblast-specific proteins such as osteocalcin (OCN), Coll-I and ALP were detected using Western blot analysis. KEY
FINDINGS: Rh1 was capable to stimulate cell growth, ALP activity, Coll-I synthesis, mineralization and glutathione content in the MC3T3-E1 cells. BMP-2 and Runx2 expression were also increased by Rh1 concentration dependently. Additionally, Rh1 also showed inhibitory action on the level of ROS production enhanced by AMA in MC3T3-E1 cells. Rh1 could increase the expression level of BMP-2/Runx2 signal-regulated osteogenic markers such as ALP, Coll-I and OCN.
CONCLUSIONS: Rh1, a protopanaxatriol type's active ingredients of Panax ginseng Meyer, possesses osteoblast differentiation, osteogenic stimulatory and anti-oxidative activity.
© 2014 Royal Pharmaceutical Society.

Entities:  

Keywords:  MC3T3-E1 cells; Panax ginseng; bone morphogenetic protein/runt-related gene 2; differentiation; ginsenosides; osteoblast

Mesh:

Substances:

Year:  2014        PMID: 25154440     DOI: 10.1111/jphp.12306

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

1.  Ginsenoside Rg5: Rk1 Exerts an Anti-obesity Effect on 3T3-L1 Cell Line by the Downregulation of PPARγ and CEBPα.

Authors:  Shakina Yesmin Simu; Sungeun Ahn; Veronica Castro-Aceituno; Deok-Chun Yang
Journal:  Iran J Biotechnol       Date:  2017-12-29       Impact factor: 1.671

2.  Therapeutic potential of compound K as an IKK inhibitor with implications for osteoarthritis prevention: an in silico and in vitro study.

Authors:  Sera Kang; Muhammad Hanif Siddiqi; Sung Joo Yoon; Sungeun Ahn; Hae-Yong Noh; Natarajan Sathish Kumar; Yeon-Ju Kim; Deok-Chun Yang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-07-01       Impact factor: 2.416

Review 3.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

4.  Ginsenoside Re Promotes Osteoblast Differentiation in Mouse Osteoblast Precursor MC3T3-E1 Cells and a Zebrafish Model.

Authors:  Hye-Min Kim; Dong Hyun Kim; Ho-Jin Han; Chan-Mi Park; Srinivas Rao Ganipisetti; Mariadhas Valan Arasu; Young Ock Kim; Chun Geun Park; Bo-Yeon Kim; Nak-Kyun Soung
Journal:  Molecules       Date:  2016-12-29       Impact factor: 4.411

Review 5.  Panax ginseng and Panax quinquefolius: From pharmacology to toxicology.

Authors:  Cesare Mancuso; Rosaria Santangelo
Journal:  Food Chem Toxicol       Date:  2017-07-08       Impact factor: 6.023

Review 6.  Emerging Natural-Product-Based Treatments for the Management of Osteoarthritis.

Authors:  Maria-Luisa Pérez-Lozano; Annabelle Cesaro; Marija Mazor; Eric Esteve; Sabine Berteina-Raboin; Thomas M Best; Eric Lespessailles; Hechmi Toumi
Journal:  Antioxidants (Basel)       Date:  2021-02-09

Review 7.  Traditional Chinese Medicine Compound-Loaded Materials in Bone Regeneration.

Authors:  Guiwen Shi; Chaohua Yang; Qing Wang; Song Wang; Gaoju Wang; Rongguang Ao; Dejian Li
Journal:  Front Bioeng Biotechnol       Date:  2022-02-18

Review 8.  Effects of ginsenosides on bone remodelling for novel drug applications: a review.

Authors:  Nan Yang; Dingkun Liu; Xiao Zhang; Jianing Li; Mi Wang; Tongtong Xu; Zhihui Liu
Journal:  Chin Med       Date:  2020-05-06       Impact factor: 5.455

Review 9.  Treatment of tibial dyschondroplasia with traditional Chinese medicines: "Lesson and future directions".

Authors:  Hui Zhang; Yajing Wang; Khalid Mehmood; Yung-Fu Chang; Zhaoxin Tang; Ying Li
Journal:  Poult Sci       Date:  2020-09-08       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.